Cinacalcet
Title: Cinacalcet
CAS Registry Number: 226256-56-0
CAS Name: (aR)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-napthalenemethanamine
Additional Names: (R)-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-(1-napthyl)ethylamine
Manufacturers' Codes: AMG-073; KRN-1493
Molecular Formula: C22H22F3N
Molecular Weight: 357.41
Percent Composition: C 73.93%, H 6.20%, F 15.95%, N 3.92%
Literature References: Calcimimetic. Prepn: B. C. Van Wagenen et al., US 6211244 (2001 to NPS Pharmaceuticals). Review of pharmacology and mechanism of action: M. Wada, N. Nagano, Nephrol. Dial. Transplant. 18, Suppl. 3, iii13-iii17 (2003); of clinical development: N. Franceschini et al., Expert Opin. Invest. Drugs 12, 1413-1421 (2003). Clinical trial in secondary hyperparathyroidism: G. A. Block et al., N. Engl. J. Med. 350, 1516 (2004).
 
Derivative Type: Hydrochloride
CAS Registry Number: 364782-34-3
Trademarks: Mimpara (Amgen); Sensipar (Amgen)
Molecular Formula: C22H22F3N.HCl
Molecular Weight: 393.87
Percent Composition: C 67.09%, H 5.89%, F 14.47%, N 3.56%, Cl 9.00%
Properties: White to off-white, crystalline solid. Sol in methanol, 95% ethanol; slightly sol in water.
 
Therap-Cat: Antihyperparathyroid.
Keywords: Antihyperparathyroid.

Others monographs:
Phenadoxone17α-Methyltestosterone 3-Cyclopentyl Enol EtherEthopropDibutyltin Dilaurate
FluprednisoloneTeriflunomideAnthrimideThrombopoietin
TamoxifenFluquinconazoleLead Hydroxide3,5-Dibromosalicylic Acid
CathinonePolicresulenDioxaphetyl ButyrateCefuroxime
©2016 DrugLead US FDA&EMEA